240 related articles for article (PubMed ID: 17162015)
1. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
Steyerberg EW; Roobol MJ; Kattan MW; van der Kwast TH; de Koning HJ; Schröder FH
J Urol; 2007 Jan; 177(1):107-12; discussion 112. PubMed ID: 17162015
[TBL] [Abstract][Full Text] [Related]
2. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
Dong F; Kattan MW; Steyerberg EW; Jones JS; Stephenson AJ; Schröder FH; Klein EA
J Urol; 2008 Jul; 180(1):150-4; discussion 154. PubMed ID: 18485398
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
4. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
Roemeling S; Roobol MJ; Kattan MW; van der Kwast TH; Steyerberg EW; Schröder FH
Cancer; 2007 Nov; 110(10):2218-21. PubMed ID: 17893906
[TBL] [Abstract][Full Text] [Related]
5. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
[TBL] [Abstract][Full Text] [Related]
6. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
7. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
8. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
Chun FK; Briganti A; Shariat SF; Graefen M; Montorsi F; Erbersdobler A; Steuber T; Salonia A; Currlin E; Scattoni V; Friedrich MG; Schlomm T; Haese A; Michl U; Colombo R; Heinzer H; Valiquette L; Rigatti P; Roehrborn CG; Huland H; Karakiewicz PI
BJU Int; 2006 Aug; 98(2):329-34. PubMed ID: 16879673
[TBL] [Abstract][Full Text] [Related]
9. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
Chun FK; Haese A; Ahyai SA; Walz J; Suardi N; Capitanio U; Graefen M; Erbersdobler A; Huland H; Karakiewicz PI
Cancer; 2008 Aug; 113(4):701-9. PubMed ID: 18553365
[TBL] [Abstract][Full Text] [Related]
10. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
11. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
Kattan MW; Eastham JA; Wheeler TM; Maru N; Scardino PT; Erbersdobler A; Graefen M; Huland H; Koh H; Shariat S; Slawin KM; Ohori M
J Urol; 2003 Nov; 170(5):1792-7. PubMed ID: 14532778
[TBL] [Abstract][Full Text] [Related]
12. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
Chun FK; Steuber T; Erbersdobler A; Currlin E; Walz J; Schlomm T; Haese A; Heinzer H; McCormack M; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2006 May; 49(5):820-6. PubMed ID: 16439050
[TBL] [Abstract][Full Text] [Related]
13. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
14. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
Benecchi L; Pieri AM; Melissari M; Potenzoni M; Pastizzaro CD
J Urol; 2008 Jul; 180(1):146-9. PubMed ID: 18485383
[TBL] [Abstract][Full Text] [Related]
15. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
Ohori M; Kattan MW; Koh H; Maru N; Slawin KM; Shariat S; Muramoto M; Reuter VE; Wheeler TM; Scardino PT
J Urol; 2004 May; 171(5):1844-9; discussion 1849. PubMed ID: 15076291
[TBL] [Abstract][Full Text] [Related]
16. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
17. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
18. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
[TBL] [Abstract][Full Text] [Related]
20. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
Steuber T; Graefen M; Haese A; Erbersdobler A; Chun FK; Schlom T; Perrotte P; Huland H; Karakiewicz PI
J Urol; 2006 Mar; 175(3 Pt 1):939-44; discussion 944. PubMed ID: 16469587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
